Galit Kleiner-Fisman

Summary

Publications

  1. ncbi request reprint Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes
    Galit Kleiner-Fisman
    Parkinson s Disease Research Education and Clinical Center, Philadelphia VA Hospital, Philadelphia, Pennsylvania 19104, USA
    Mov Disord 21:S290-304. 2006
  2. doi request reprint Benign hereditary chorea
    Galit Kleiner-Fisman
    Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital and Baycrest Geriatric Hospital, University of Toronto, Toronto, Canada
    Handb Clin Neurol 100:199-212. 2011
  3. pmc Development of a non-motor fluctuation assessment instrument for Parkinson disease
    Galit Kleiner-Fisman
    Baycrest Hospital, University of Toronto, 3560 Bathurst Street, Toronto, ON, Canada M6A 2E1
    Parkinsons Dis 2011:292719. 2011
  4. pmc A Patient-Based Needs Assessment for Living Well with Parkinson Disease: Implementation via Nominal Group Technique
    Galit Kleiner-Fisman
    ATC and Jeff and Diane Ross Movement Disorders Clinic, Baycrest Hospital, University of Toronto, 3560 Bathurst Street, Toronto, ON, Canada M6A 2E1
    Parkinsons Dis 2013:974964. 2013
  5. ncbi request reprint Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life
    Galit Kleiner-Fisman
    Philadelphia Parkinson s Disease Research Education and Clinical Center, Philadelphia Veterans Administration Hospital, USA
    J Neurosurg 107:29-36. 2007
  6. ncbi request reprint Risk factors for the development of pedal edema in patients using pramipexole
    Galit Kleiner-Fisman
    Parkinson s disease Clinical Center, Philadelphia VA Hospital, University of Pennsylvania, USA
    Arch Neurol 64:820-4. 2007
  7. doi request reprint Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesia
    Galit Kleiner-Fisman
    Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 25:1496-8. 2010
  8. ncbi request reprint Subthalamic nucleus deep brain stimulation for parkinson's disease after successful pallidotomy: clinical and electrophysiological observations
    Galit Kleiner-Fisman
    Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 19:1209-14. 2004
  9. pmc Health-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans
    Galit Kleiner-Fisman
    Department of Neurology, Baycrest Geriatric Hospital, Toronto, Ontario, Canada
    Health Qual Life Outcomes 8:91. 2010
  10. ncbi request reprint Motor cortical stimulation for parkinsonism in multiple system atrophy
    Galit Kleiner-Fisman
    Division of Neurology and Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Ontario
    Arch Neurol 60:1554-8. 2003

Collaborators

Detail Information

Publications29

  1. ncbi request reprint Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes
    Galit Kleiner-Fisman
    Parkinson s Disease Research Education and Clinical Center, Philadelphia VA Hospital, Philadelphia, Pennsylvania 19104, USA
    Mov Disord 21:S290-304. 2006
    ..These data provide an estimate of the magnitude of the treatment effects and emphasize the need for controlled and randomized studies...
  2. doi request reprint Benign hereditary chorea
    Galit Kleiner-Fisman
    Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital and Baycrest Geriatric Hospital, University of Toronto, Toronto, Canada
    Handb Clin Neurol 100:199-212. 2011
    ..This chapter reviews the historical literature and current understanding regarding this familial, developmental disorder...
  3. pmc Development of a non-motor fluctuation assessment instrument for Parkinson disease
    Galit Kleiner-Fisman
    Baycrest Hospital, University of Toronto, 3560 Bathurst Street, Toronto, ON, Canada M6A 2E1
    Parkinsons Dis 2011:292719. 2011
    ..Patient-based nominal group technique sessions, focus groups, and expert opinion were utilized in developing this questionnaire...
  4. pmc A Patient-Based Needs Assessment for Living Well with Parkinson Disease: Implementation via Nominal Group Technique
    Galit Kleiner-Fisman
    ATC and Jeff and Diane Ross Movement Disorders Clinic, Baycrest Hospital, University of Toronto, 3560 Bathurst Street, Toronto, ON, Canada M6A 2E1
    Parkinsons Dis 2013:974964. 2013
    ....
  5. ncbi request reprint Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life
    Galit Kleiner-Fisman
    Philadelphia Parkinson s Disease Research Education and Clinical Center, Philadelphia Veterans Administration Hospital, USA
    J Neurosurg 107:29-36. 2007
    ..Outcomes have varied depending on the features of the dystonia. There has been limited literature regarding outcomes for refractory dystonia following DBS of the subthalamic nucleus (STN)...
  6. ncbi request reprint Risk factors for the development of pedal edema in patients using pramipexole
    Galit Kleiner-Fisman
    Parkinson s disease Clinical Center, Philadelphia VA Hospital, University of Pennsylvania, USA
    Arch Neurol 64:820-4. 2007
    ..To determine risk factors for pedal edema among patients with Parkinson disease (PD) using pramipexole hydrochloride therapy...
  7. doi request reprint Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesia
    Galit Kleiner-Fisman
    Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 25:1496-8. 2010
    ..Though sample size was small, there was a trend towards a reduction in LID lasting up to 12 years suggesting that posteroventral pallidotomy may provide sustained benefit in reducing LID...
  8. ncbi request reprint Subthalamic nucleus deep brain stimulation for parkinson's disease after successful pallidotomy: clinical and electrophysiological observations
    Galit Kleiner-Fisman
    Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 19:1209-14. 2004
    ..017, 0.005). There were no side-to-side differences clinically or in the STN neuronal firing rates and patterns. Bilateral STN DBS is safe and efficacious in improving motor symptoms in patients with prior pallidotomy...
  9. pmc Health-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans
    Galit Kleiner-Fisman
    Department of Neurology, Baycrest Geriatric Hospital, Toronto, Ontario, Canada
    Health Qual Life Outcomes 8:91. 2010
    ....
  10. ncbi request reprint Motor cortical stimulation for parkinsonism in multiple system atrophy
    Galit Kleiner-Fisman
    Division of Neurology and Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Ontario
    Arch Neurol 60:1554-8. 2003
    ..We hypothesized that direct cortical stimulation could alleviate the disability of the treatment-refractory parkinsonian symptoms commonly present in MSA...
  11. ncbi request reprint Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease
    Galit Kleiner-Fisman
    Division of Neurology and Neurosurgery, Toronto Western Hospital, University of Toronto, Ontario, Canada
    J Neurosurg 99:489-95. 2003
    ..The authors present the long-term results of a cohort of 25 individuals who underwent bilateral DBS of the STN between 1996 and 2001 and were followed up for 1 year or longer after implantation of the stimulator...
  12. ncbi request reprint Alterations of striatal neurons in benign hereditary chorea
    Galit Kleiner-Fisman
    Parkinson s Disease Research, Education and Clinical Center PADRECC, Philadelphia VA Hospital, Philadelphia, Pennsylvania 19104, USA
    Mov Disord 20:1353-7. 2005
    ..There was a loss of most TITF-1-mediated striatal interneurons in the BHC specimen compared to four matched control brains...
  13. ncbi request reprint Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease
    Daniel Weintraub
    Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Nucl Med 46:227-32. 2005
    ..We studied the correlation of striatal dopamine transporter (DAT) imaging with anxiety and depression symptoms in Parkinson's disease (PD)...
  14. pmc Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis
    Carmen Gasca-Salas
    The Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson s Disease, TWH, Toronto, Canada
    PLoS ONE 11:e0153852. 2016
    ..Although behavior, language and movement presentations are common, the relationship between genetic subgroup and movement disorder phenomenology is unclear...
  15. ncbi request reprint Rapidly progressive behavioral changes and parkinsonism in a 68-year-old man
    Galit Kleiner-Fisman
    Department of Medicine, Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 19:534-43. 2004
  16. ncbi request reprint Falling risk factors in Parkinson's disease
    Keith Robinson
    Department of Rehabilitation Medicine, University of Pennsylvania, Philadelphia, PA, USA
    NeuroRehabilitation 20:169-82. 2005
    ..To identify falling risk factors that are potentially modifiable among individuals who have idiopathic Parkinson's disease...
  17. ncbi request reprint Insights into brain function through the examination of art: the influence of neurodegenerative diseases
    Galit Kleiner-Fisman
    Parkinson s Disease Research, Education and Clinical Center PADRECC, Philadelphia VA Hospital, University of Pennsylvania, 3900 Woodland Ave, Philadelphia, PA 19104, USA
    Neuroreport 15:933-7. 2004
    ..We present examples of each, illustrating both perspectives and suggest that the two opposing views may not be mutually exclusive...
  18. ncbi request reprint Benign hereditary chorea revisited: a journey to understanding
    Galit Kleiner-Fisman
    Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 22:2297-305; quiz 2452. 2007
    ..This review summarizes both a historical perspective and our current understanding of BHC...
  19. doi request reprint Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders
    Andrew D Robertson
    Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada
    Parkinsonism Relat Disord 22:80-6. 2016
    ..This proof-of-concept study examined cerebral blood flow (perfusion) as a mediator of orthostatic hypotension and cognition...
  20. ncbi request reprint Benign hereditary chorea: clinical, genetic, and pathological findings
    Galit Kleiner-Fisman
    Division of Neurology, Toronto Western Hospital, Ontario, Canada
    Ann Neurol 54:244-7. 2003
    ..1, and T/ebp) on chromosome 14 which is predicted to have drastic consequences on the maturation processes of TITF-1...
  21. ncbi request reprint Neurodegenerative disease and the evolution of art: the effects of presumed corticobasal degeneration in a professional artist
    Galit Kleiner-Fisman
    Morton and Gloria Shulman Movement Disorders Center, Division of Neurology, The Toronto Hospital, University of Toronto, Western Division, 399 Bathurst Street, MP11 306, Toronto, Ontario M5T 2S8, Canada
    Mov Disord 18:294-302. 2003
    ..Our case study adds to the growing literature on the effects of brain damage on artistic expression in the graphic arts...
  22. ncbi request reprint Presentation of Creutzfeldt-Jakob disease as acute corticobasal degeneration syndrome
    Galit Kleiner-Fisman
    Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
    Mov Disord 19:948-9. 2004
    ..We provide a brief report with videotape documentation of a possible case of Creutzfeldt-Jakob disease...
  23. pmc A randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairment
    Galit Kleiner-Fisman
    Jeff and Diane Ross Movement Disorders Clinic, Assistive Technology Clinic, Toronto, Canada Baycrest Center for Geriatric Health, University of Toronto, Toronto, Canada Department of Medicine, Division of Neurology, University of Toronto, Toronto, Canada
    PLoS ONE 9:e114733. 2014
    ..Evaluate safety and efficacy of Incobotulinumtoxin A in elderly patients with dementia and paratonia...
  24. ncbi request reprint Voluntary control and a wider clinical spectrum of essential palatal tremor
    Michael Samuel
    Morton and Gloria Shulman Movement Disorder Centre, Toronto Western Hospital, Toronto, Ontario, Canada
    Mov Disord 19:717-9. 2004
    ..We present two patients who had some "voluntary control" over EPT, including entrainment. We review the English language literature on EPT to describe a wider clinical spectrum of this syndrome...
  25. ncbi request reprint Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease
    Grace S Liang
    The Parkinson s Institute, Sunnyvale, CA, USA
    Stereotact Funct Neurosurg 84:221-7. 2006
    ..However, the long-term benefits of DBS are not yet established...
  26. ncbi request reprint Deep brain stimulation: postoperative issues
    Gunther Deuschl
    Department of Neurology, Christian Albrechts Universitat Kiel, Kiel, Germany
    Mov Disord 21:S219-37. 2006
    ..The report has been endorsed by the Scientific Issues Committee of the Movement Disorder Society and the American Society of Stereotactic and Functional Neurosurgery...
  27. ncbi request reprint Phenylthiocarbamide (PTC) perception in Parkinson disease
    Paul J Moberg
    Parkinson s Disease Research, Education, and Clinical Center, Philadelphia Veterans Affairs Medical Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Cogn Behav Neurol 20:145-8. 2007
    ..To examine phenylthiocarbamide (PTC) sensitivity in Parkinson disease (PD) patients and healthy volunteers to determine whether taster status represented a simple vulnerability marker for PD...
  28. ncbi request reprint Treatment of levodopa-induced dyskinesias with donepezil
    Stanley N Caroff
    Parkinsonism Relat Disord 12:261-3. 2006
  29. ncbi request reprint Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists
    Judit Horvath
    Department of Neurology, University Hospital, Geneva, Switzerland
    Mov Disord 19:656-62. 2004
    ..Therefore, until more is known about the true prevalence of this side effect, we propose that an assessment of cardiac function be performed before and in the course of a long-term therapy with ergot derivative dopamine agonists...